Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05116293

Effect of Testosterone Treatment on Drug Metabolism and Transport

Effect of Gender-Affirming Testosterone Therapy on Drug Metabolism, Transport, and Gut Microbiota

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
12 (estimated)
Sponsor
University of Washington · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

This project will evaluate the effect of gender-affirming testosterone treatment on how other medications are processed by the body.

Detailed description

Gender-affirming hormone therapy may include testosterone, a hormone that the body creates and uses naturally. Testosterone is prepared as a medication that patients may take to increase hormone levels. Changes in testosterone concentrations in the body may affect how the body processes other medicines. The purpose of this study is to find out how testosterone therapy affects a single tracer dose of approved medicines in the blood (midazolam, digoxin, and acetaminophen) and to confirm testosterone treatment does not affect natural bacterial in the gut.

Conditions

Interventions

TypeNameDescription
DRUGMidazolam oral solutionOral syrup
DRUGDigoxin Oral TabletOral tablet
DRUGAcetaminophen Oral TabletOral tablet

Timeline

Start date
2021-05-01
Primary completion
2024-02-15
Completion
2025-12-31
First posted
2021-11-11
Last updated
2025-06-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05116293. Inclusion in this directory is not an endorsement.